Phenytoin pharmacokinetics: inappropriate data analysis. 1982

T H Grasela, and M E Winter

UI MeSH Term Description Entries
D007700 Kinetics The rate dynamics in chemical or physical systems.
D010672 Phenytoin An anticonvulsant that is used to treat a wide variety of seizures. It is also an anti-arrhythmic and a muscle relaxant. The mechanism of therapeutic action is not clear, although several cellular actions have been described including effects on ion channels, active transport, and general membrane stabilization. The mechanism of its muscle relaxant effect appears to involve a reduction in the sensitivity of muscle spindles to stretch. Phenytoin has been proposed for several other therapeutic uses, but its use has been limited by its many adverse effects and interactions with other drugs. Diphenylhydantoin,Fenitoin,Phenhydan,5,5-Diphenylhydantoin,5,5-diphenylimidazolidine-2,4-dione,Antisacer,Difenin,Dihydan,Dilantin,Epamin,Epanutin,Hydantol,Phenytoin Sodium,Sodium Diphenylhydantoinate,Diphenylhydantoinate, Sodium
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

T H Grasela, and M E Winter
February 1989, Journal of clinical pharmacy and therapeutics,
T H Grasela, and M E Winter
January 1983, Clinical pharmacokinetics,
T H Grasela, and M E Winter
February 1976, Clinical pharmacology and therapeutics,
T H Grasela, and M E Winter
January 1979, Clinical pharmacokinetics,
T H Grasela, and M E Winter
June 1985, American journal of clinical pathology,
T H Grasela, and M E Winter
July 1990, Chemical & pharmaceutical bulletin,
T H Grasela, and M E Winter
November 1981, British journal of clinical pharmacology,
T H Grasela, and M E Winter
July 1984, Neurology,
T H Grasela, and M E Winter
January 1985, Journal of clinical pharmacology,
Copied contents to your clipboard!